Efficacy of infliximab in psoriatic arthritis resistant to treatment with disease modifying antirheumatic drugs: an open pilot study

類似資料

• Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response
  著者:: Rinaldi, F, 等
  出版事項: (2005)
• Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis
  著者:: Syngle, Ashit, 等
  出版事項: (2016)
• Validity of Psoriatic Arthritis and Capture of Disease Modifying Antirheumatic Drugs in The Health Improvement Network
  著者:: Ogdie, Alexis, 等
  出版事項: (2014)
• Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
  著者:: Kingsley, Gabrielle H, 等
  出版事項: (2015)
• Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
  著者:: Gladman, Dafna D., 等
  出版事項: (2020)